HK1212999A1 - 用於治療和/或限制糖尿病的發展的方法 - Google Patents

用於治療和/或限制糖尿病的發展的方法

Info

Publication number
HK1212999A1
HK1212999A1 HK16100868.1A HK16100868A HK1212999A1 HK 1212999 A1 HK1212999 A1 HK 1212999A1 HK 16100868 A HK16100868 A HK 16100868A HK 1212999 A1 HK1212999 A1 HK 1212999A1
Authority
HK
Hong Kong
Prior art keywords
diabetes
treating
methods
limiting development
development
Prior art date
Application number
HK16100868.1A
Other languages
English (en)
Inventor
Per-Olof Berggren
Lisa Juntti-Berggren
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Publication of HK1212999A1 publication Critical patent/HK1212999A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
HK16100868.1A 2013-03-13 2016-01-26 用於治療和/或限制糖尿病的發展的方法 HK1212999A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361779508P 2013-03-13 2013-03-13
PCT/EP2014/054862 WO2014140113A1 (en) 2013-03-13 2014-03-12 Methods for treating and/or limiting development of diabetes

Publications (1)

Publication Number Publication Date
HK1212999A1 true HK1212999A1 (zh) 2016-06-24

Family

ID=50241460

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100868.1A HK1212999A1 (zh) 2013-03-13 2016-01-26 用於治療和/或限制糖尿病的發展的方法

Country Status (9)

Country Link
EP (1) EP2970463B1 (zh)
JP (2) JP6456853B2 (zh)
KR (1) KR20150127717A (zh)
CN (1) CN104968681B (zh)
DK (1) DK2970463T3 (zh)
ES (1) ES2657090T3 (zh)
HK (1) HK1212999A1 (zh)
PL (1) PL2970463T3 (zh)
WO (1) WO2014140113A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201509575D0 (en) * 2015-06-03 2015-07-15 King S College London Diagnostic target
US10111932B2 (en) 2015-08-26 2018-10-30 Syracuse University Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor
CN117106024A (zh) * 2022-10-21 2023-11-24 南京市妇幼保健院 一种人血清多肽agdmp1及其在改善胰岛素抵抗中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033597B2 (en) * 2000-10-13 2006-04-25 Université de Lausanne Intracellular delivery of biological effectors
EP1623228B1 (en) * 2003-04-29 2012-12-05 BioCrine AB Apociii and the treatment and diagnosis of diabetes
WO2007097751A1 (en) * 2006-02-22 2007-08-30 The Regents Of The University Of Michigan Methods for reducing glucose intolerance by inhibiting chop
US9023820B2 (en) * 2009-01-26 2015-05-05 Protiva Biotherapeutics, Inc. Compositions and methods for silencing apolipoprotein C-III expression
KR20130097789A (ko) * 2010-10-15 2013-09-03 코넬 유니버시티 내분비, 위장관 또는 자가면역 장애 치료를 위한 조성물 및 방법
US8557513B2 (en) * 2011-06-27 2013-10-15 Biocrine Ab Methods for treating and/or limiting development of diabetes

Also Published As

Publication number Publication date
JP2019065025A (ja) 2019-04-25
DK2970463T3 (en) 2018-01-22
CN104968681A (zh) 2015-10-07
CN104968681B (zh) 2020-03-17
JP6456853B2 (ja) 2019-01-23
EP2970463B1 (en) 2017-11-29
PL2970463T3 (pl) 2018-04-30
EP2970463A1 (en) 2016-01-20
JP2016517400A (ja) 2016-06-16
KR20150127717A (ko) 2015-11-17
ES2657090T3 (es) 2018-03-01
WO2014140113A1 (en) 2014-09-18
JP7111605B2 (ja) 2022-08-02

Similar Documents

Publication Publication Date Title
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
HK1225654A1 (zh) 用於治療老花眼的組合物及方法
GB201413234D0 (en) Security device and method of manufacture
EP2970317A4 (en) PYRIMIDODIAZEPINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF DISEASES
GB201320723D0 (en) Composition and methods of treatment
PT2948448T (pt) Análogos de tiadiazol e o seu uso para tratamento de doenças associadas a uma deficiência de neurónios motores smn
HK1232235A1 (zh) 治療和診斷過表達α- -β- 的癌症的方法
GB2513304B (en) Peripheral apparatus and method of construction
HK1224307A1 (zh) 原毒素- 變體及其使用方法
HK1214355A1 (zh) 用於治療和/或限制糖尿病發展的方法
PL3074038T3 (pl) Sposób leczenia nefropatii cukrzycowej
IL241096B (en) Treatment methods
HK1212999A1 (zh) 用於治療和/或限制糖尿病的發展的方法
HRP20181445T1 (hr) Sastavi i postupci za liječenje dijabetesa tipa 1
ZA201601626B (en) Treatment of gases
GB201311984D0 (en) Methods and compounds for preventing or treating osteoarthritis
HK1223034A1 (zh) 用於治療 型糖尿病的方法和養生方案
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
GB201321848D0 (en) Lock means and method of use thereof
ZA201302565B (en) Methods for treating hyperuricemia and related diseases
GB201302105D0 (en) Cover Means and Method of Use Thereof
AU2013904467A0 (en) Regimen and method for treatment of type 2 diabetes

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220311